Vittorio M. Morreale – Trademark Portfolio

Entity Type: 01

Vittorio M. Morreale holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 2 filings in this category. The portfolio also extends into Class 43 (Hotels & Restaurants) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include KYFUSION and KYPHOFUSION. The owner is based in Rochester, MI.

523 Ridgewood Road

Rochester, MI 48306

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Vittorio M. Morreale's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (2 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

43
Hotels & Restaurants (1 filing)

Services for providing food and drink; temporary accommodation

Frequently Asked Questions

How many trademarks does Vittorio M. Morreale have?

Vittorio M. Morreale has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Vittorio M. Morreale file in?

Vittorio M. Morreale files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 43 (Hotels & Restaurants). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What are Vittorio M. Morreale's most well-known trademarks?

Vittorio M. Morreale's registered trademark portfolio includes well-known marks such as KYFUSION and KYPHOFUSION. These are among 2 currently registered trademarks in the portfolio.

What is Vittorio M. Morreale's trademark registration success rate?

Vittorio M. Morreale has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.